Literature DB >> 19799892

Downstream of FGF during mesoderm formation in Xenopus: the roles of Elk-1 and Egr-1.

Oliver Nentwich1, Kevin S Dingwell, A Nordheim, J C Smith.   

Abstract

Signalling by members of the FGF family is required for induction and maintenance of the mesoderm during amphibian development. One of the downstream effectors of FGF is the SRF-interacting Ets family member Elk-1, which, after phosphorylation by MAP kinase, activates the expression of immediate-early genes. Here, we show that Xenopus Elk-1 is phosphorylated in response to FGF signalling in a dynamic pattern throughout the embryo. Loss of XElk-1 function causes reduced expression of Xbra at neurula stages, followed by a failure to form notochord and muscle and then the partial loss of trunk structures. One of the genes regulated by XElk-1 is XEgr-1, which encodes a zinc finger transcription factor: we show that phosphorylated XElk-1 forms a complex with XSRF that binds to the XEgr-1 promoter. Superficially, Xenopus tropicalis embryos with reduced levels of XEgr-1 resemble those lacking XElk-1, but to our surprise, levels of Xbra are elevated at late gastrula stages in such embryos, and over-expression of XEgr-1 causes the down-regulation of Xbra both in whole embryos and in animal pole regions treated with activin or FGF. In contrast, the myogenic regulatory factor XMyoD is activated by XEgr-1 in a direct manner. We discuss these counterintuitive results in terms of the genetic regulatory network to which XEgr-1 contributes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799892     DOI: 10.1016/j.ydbio.2009.09.039

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  14 in total

Review 1.  Wnt signaling in vertebrate axis specification.

Authors:  Hiroki Hikasa; Sergei Y Sokol
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

Review 2.  Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent.

Authors:  Faruk Hadziselimovic
Journal:  Mol Syndromol       Date:  2016-02-02

3.  Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.

Authors:  Amanda L Evans; Tiago Faial; Michael J Gilchrist; Thomas Down; Ludovic Vallier; Roger A Pedersen; Fiona C Wardle; James C Smith
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

4.  Theoretical basis of the community effect in development.

Authors:  Yasushi Saka; Cédric Lhoussaine; Celine Kuttler; Ekkehard Ullner; Marco Thiel
Journal:  BMC Syst Biol       Date:  2011-04-17

5.  Inferring dynamic gene regulatory networks in cardiac differentiation through the integration of multi-dimensional data.

Authors:  Wuming Gong; Naoko Koyano-Nakagawa; Tongbin Li; Daniel J Garry
Journal:  BMC Bioinformatics       Date:  2015-03-07       Impact factor: 3.169

6.  Expression Pattern of Early Growth Response Gene 1 during Olive Flounder (Paralichthys olivaceus) Embryonic Development.

Authors:  Hyun Yang; Jeong-Ho Lee; Jae Koo Noh; Hyun Chul Kim; Choul-Ji Park; Jong-Won Park; Kyung-Kil Kim
Journal:  Dev Reprod       Date:  2014-12

7.  Fibroblast growth factor (FGF) signaling in development and skeletal diseases.

Authors:  Chad M Teven; Evan M Farina; Jane Rivas; Russell R Reid
Journal:  Genes Dis       Date:  2014-12-01

Review 8.  Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development.

Authors:  Charles Ducker; Peter E Shaw
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  Mef2d acts upstream of muscle identity genes and couples lateral myogenesis to dermomyotome formation in Xenopus laevis.

Authors:  Bruno Della Gaspera; Anne-Sophie Armand; Sylvie Lecolle; Frédéric Charbonnier; Christophe Chanoine
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  Transcriptional regulation of mesoderm genes by MEF2D during early Xenopus development.

Authors:  Alina Kolpakova; Sandra Katz; Aviad Keren; Adi Rojtblat; Eyal Bengal
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.